Today: Today, HCP Inc. (HCP) Position Increased by W.G. Shaheen & Associates DBA Whitney & Co

Today, HCP Inc. (HCP) Position Increased by W.G. Shaheen & Associates DBA Whitney & Co

W.G. Shaheen & Associates DBA Whitney & Co boosted its stake in HCP Inc. (NYSE:HCP) by 2.9% during the third quarter, Holdings Channel reports. The firm owned 65,545 shares of the real estate investment trust’s stock after buying an additional 1,825 shares during the period. W.G. Shaheen & Associates DBA Whitney & Co’s holdings in HCP were worth $2,487,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Nuveen Asset Management LLC boosted its position in HCP by 6.2% in the first quarter. Nuveen Asset Management LLC now owns 31,204 shares of the real estate investment trust’s stock valued at $1,017,000 after buying an additional 1,826 shares during the period. Jacobs Levy Equity Management Inc. purchased a new position in HCP during the first quarter valued at $756,000. Arizona State Retirement System boosted its position in HCP by 2.6% in the first quarter. Arizona State Retirement System now owns 193,044 shares of the real estate investment trust’s stock valued at $6,289,000 after buying an additional 4,900 shares during the period. Royal Bank of Canada boosted its position in HCP by 0.3% in the first quarter. Royal Bank of Canada now owns 683,987 shares of the real estate investment trust’s stock valued at $22,283,000 after buying an additional 1,757 shares during the period. Finally, Squarepoint Ops LLC purchased a new position in HCP during the first quarter valued at $886,000. Institutional investors and hedge funds own 92.07% of the company’s stock.

Shares of HCP Inc. (NYSE:HCP) traded up 0.41% during mid-day trading on Monday, hitting $29.38. 4,247,361 shares of the company were exchanged. The company has a 50 day moving average of $30.73 and a 200 day moving average of $32.83. HCP Inc. has a 52 week low of $22.87 and a 52 week high of $36.82. The company’s market capitalization is $13.75 billion.

HCP (NYSE:HCP) last released its quarterly earnings data on Tuesday, November 1st. The real estate investment trust reported $0.72 earnings per share for the quarter, beating analysts’ consensus estimates of $0.71 by $0.01. The business earned $654.30 million during the quarter, compared to analyst estimates of $634.11 million. HCP had a negative net margin of 1.16% and a negative return on equity of 0.32%. During the same period last year, the business earned $0.79 EPS. Equities analysts anticipate that HCP Inc. will post $2.74 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 25th. Shareholders of record on Thursday, November 10th were paid a dividend of $0.37 per share. The ex-dividend date was Tuesday, November 8th. This represents a $1.48 dividend on an annualized basis and a yield of 5.04%. HCP’s dividend payout ratio is currently -1,850.00%.

HCP has been the topic of several analyst reports. Mizuho boosted their price target on shares of HCP from $32.00 to $37.00 and gave the stock a “neutral” rating in a report on Wednesday, August 10th. Citigroup Inc. boosted their price target on shares of HCP from $34.00 to $38.00 and gave the stock a “neutral” rating in a report on Wednesday, August 24th. BTIG Research initiated coverage on shares of HCP in a report on Thursday, August 25th. They set a “neutral” rating on the stock. Wells Fargo & Co. restated a “hold” rating on shares of HCP in a report on Sunday, September 4th. Finally, Argus restated a “hold” rating on shares of HCP in a report on Sunday, September 18th. Four investment analysts have rated the stock with a sell rating, fourteen have issued a hold rating, two have given a buy rating and one has issued a strong buy rating to the company’s stock. HCP presently has an average rating of “Hold” and an average target price of $34.33.

In other news, insider Thomas D. Kirby sold 3,000 shares of HCP stock in a transaction that occurred on Wednesday, September 7th. The shares were sold at an average price of $40.24, for a total value of $120,720.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Darren A. Kowalske sold 2,250 shares of HCP stock in a transaction that occurred on Wednesday, August 31st. The stock was sold at an average price of $39.20, for a total transaction of $88,200.00. Following the completion of the sale, the insider now owns 9,793 shares of the company’s stock, valued at $383,885.60. The disclosure for this sale can be found here. Company insiders own 0.22% of the company’s stock.

About HCP

HCP, Inc (HCP) is a self-administered real estate investment trust (REIT). The Company invests in real estate serving the healthcare industry in the United States. Its portfolio consists of investments in various healthcare segments: senior housing, post-acute/skilled nursing, life science, medical office and hospital.

Related posts

Leave a Comment